Clinical Trials Directory

Trials / Sponsors / Oramed, Ltd.

Oramed, Ltd.

Industry · 13 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.
Type 2 Diabetes Mellitus
Phase 32025-12-15
TerminatedA Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
T2DM (Type 2 Diabetes Mellitus)
Phase 32021-03-16
CompletedA Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepati
Nonalcoholic Steatohepatitis (NASH)
Phase 22021-03-01
TerminatedStudy to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 32020-12-15
CompletedA Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (
Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis
Phase 22020-11-24
CompletedA Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
Phase 22020-11-23
CompletedA Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes
Type 1 Diabetes
Phase 22019-10-17
CompletedA Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)
Non-Alcoholic Steatohepatitis (NASH), Type2 Diabetes Mellitus
Phase 22018-09-20
CompletedA Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Melli
T2DM (Type 2 Diabetes Mellitus)
Phase 22018-05-29
CompletedA Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Phase 22016-10-01
CompletedPhase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Diabetes Type 2
Phase 22015-07-27
CompletedA Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin C
Diabetes Mellitus Type 1
Phase 22014-03-01
CompletedSafety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult P
Diabetes Mellitus Type 2
Phase 22013-06-01